Financials data is unavailable for this security.
View more
Year on year Muromachi Chemicals Inc had relatively flat revenues (6.29bn to 6.37bn), though the company grew net income 28.83% from 256.30m to 330.20m. A reduction in the cost of goods sold as a percentage of sales from 72.15% to 70.88% was a component in the net income growth despite flat revenues.
| Gross margin | 29.12% |
|---|---|
| Net profit margin | 5.18% |
| Operating margin | 7.13% |
| Return on assets | 6.60% |
|---|---|
| Return on equity | 15.77% |
| Return on investment | 10.39% |
More ▼
Cash flow in JPYView more
In 2024, Muromachi Chemicals Inc increased its cash reserves by 23.20%, or 197.82m. The company earned 637.70m from its operations for a Cash Flow Margin of 10.01%. In addition the company used 232.23m on investing activities and also paid 209.95m in financing cash flows.
| Cash flow per share | 115.62 |
|---|---|
| Price/Cash flow per share | 6.53 |
| Book value per share | 571.26 |
|---|---|
| Tangible book value per share | 555.02 |
More ▼
Balance sheet in JPYView more
| Current ratio | 2.18 |
|---|---|
| Quick ratio | 1.62 |
| Total debt/total equity | 0.6329 |
|---|---|
| Total debt/total capital | 0.3876 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 15.79% and 27.67%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend. Additionally, five year annualized earnings per share growth ranks highest in its industry.
| Div yield(5 year avg) | 1.85% |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 26.49% |
| EPS growth(5 years) | 41.45 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 26.05 |
More ▼
